Description
What it is
GLP-1 receptor agonist. EU-approved for type-2 diabetes and chronic weight management.
Mechanism
Semaglutide activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying and promote satiety.
Specifications
- Peptide content: 5mg / vial
- HPLC purity: ≥99.5%
- Form: Lyophilized powder
- Storage: 2–8°C, protected from light
- Shipping: Cold-chain dispatch from EU warehouse, same-day if ordered before 14:00 CET
Certificate of Analysis
Every batch ships with a downloadable Certificate of Analysis showing HPLC purity, mass-spec identity confirmation, and microbial/endotoxin pass results.
Reviews
There are no reviews yet.